Jinyu Bio-technology Co., Ltd. (SHA:600201)
17.60
+0.31 (1.79%)
Jan 22, 2026, 3:00 PM CST
Jinyu Bio-technology Market Cap
Jinyu Bio-technology has a market cap or net worth of 19.23 billion as of January 22, 2026. Its market cap has increased by 147.36% in one year.
Market Cap
19.23B
Enterprise Value
18.04B
Revenue
1.33B
Ranking
n/a
PE Ratio
183.19
Stock Price
17.60
Market Cap Chart
Since January 18, 1999, Jinyu Bio-technology's market cap has increased from 977.52M to 19.23B, an increase of 1,867.45%. That is a compound annual growth rate of 11.65%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 22, 2026 | 19.23B | 16.79% |
| Dec 31, 2025 | 16.47B | 114.89% |
| Dec 31, 2024 | 7.66B | -34.56% |
| Dec 29, 2023 | 11.71B | 18.94% |
| Dec 30, 2022 | 9.85B | -46.16% |
| Dec 31, 2021 | 18.29B | -22.27% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Yili Chuanning Biotechnology | 24.69B |
| DaShenLin Pharmaceutical Group | 22.66B |
| Suzhou Zelgen Biopharmaceuticals | 22.63B |
| BrightGene Bio-Medical Technology | 21.09B |
| Sinocelltech Group | 20.25B |
| Inner Mongolia Furui Medical Science | 19.58B |
| Anhui Anke Biotechnology (Group) | 17.09B |
| InventisBio | 15.92B |